Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), glaucoma, and traumatic brain injury. Our treatment, AXER-204, hopes to rebuild connections between healthy and damaged neurons through the blocking of receptors that naturally inhibit axonal growth. We are currently approaching Phase 2 of testing.
View Top Employees from ReNetX Bio| Website | http://www.renetx.com |
| Revenue | $6 million |
| Employees | 7 (0 on RocketReach) |
| Address | 157 Church Street 19th Floor, New Haven, Connecticut 06510, US |
| Phone | (203) 444-6642 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+11 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services |
| Competitors | August Therapeutics, Inc, Convelo Therapeutics, Inc, Novoron Bioscience, Q Therapeutics, Velesco Pharmaceutical Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular ReNetX Bio employee's phone or email?
ReNetX Bio Questions
The ReNetX Bio annual revenue was $6 million in 2024.
ReNetX Bio is based in New Haven, Connecticut.
The NAICS codes for ReNetX Bio are [541713, 541, 54171, 54, 5417].
The SIC codes for ReNetX Bio are [873, 87].
Related Companies
